Gerald Durrell’s Centenary: a year of celebrations starts today
January 10, 2025
Zebra dies after ‘incident’with rhino at zoo
January 10, 2025
The FINANCIAL -- Data from the ToGA study presented on May 31 at the American Society for Clinical Oncology Annual Meeting in...
The FINANCIAL -- Roche announced on May 30 that the Phase III ATLAS study showed patients with advanced non-small cell lung cancer...
The FINANCIAL -- Full results from the first phase III trial of Avastin (bevacizumab) in early-stage colon cancer, known as...
The FINANCIAL -- Pfizer announced on May 30 results from studies evaluating the company’s investigational anti-insulin growth factor- type 1 receptor (IGF-1R)...
The FINANCIAL -- Pfizer announced on May 30 results from four studies highlighting clinical data with targeted treatment approaches in patients with...
The FINANCIAL -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) and its fully owned subsidiary, BiPar Sciences, on May 31 announced results from...
The FINANCIAL -- Reclast (zoledronic acid 5 mg) Injection[] has been approved by the US Food and Drug Administration (FDA)...
The FINANCIAL -- Daiichi Sankyo Co., Ltd. and Ranbaxy Laboratories Limited on May 24 announced that Mr. Malvinder Mohan Singh has...
The FINANCIAL -- Roche announced on May 25 that new two-year data from the LITHE study1 demonstrate that ACTEMRA (tocilizumab, known as...
The FINANCIAL -- Sanofi Pasteur, the vaccines division of the sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced on May 25 it...
The FINANCIAL -- Takeda Pharmaceutical Company Limited (TSE: 4502) and IDM Pharma, Inc. (NASDAQ: IDMI) on May 18 announced that Takeda...
The FINANCIAL -- King Pharmaceuticals, Inc. (NYSE:KG) announced on May 11 that total revenues were $429 million during the first quarter ended...
The FINANCIAL -- The Association of German Medical Journalists presented for the first time the Advances in Renal Cancer Journalists’...
The FINANCIAL -- Schering-Plough Corporation (NYSE: SGP) on April 27 reported that final results of three large PEGINTRON(TM) (peginterferon alfa-2b) clinical studies address...
The FINANCIAL -- Bayer HealthCare AG and Onyx Pharmaceuticals, Inc. on April 27 announced that a Phase III trial evaluating Nexavar (sorafenib)...